Skip to main content
Fig. 3 | Cell & Bioscience

Fig. 3

From: Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies

Fig. 3

The neutralization titers of mAbs secreted by six most potent neutralizing MSCs clones against Omicron variants. (a) Neutralizing potency of three mAbs (2–15, XGv347, and LY-CoV1404) secreted by six most potent neutralizing MSC clones against pseudoviruses of wild type (WT) and the Omicron subvariants including BA.1, BA.1-R293K, BA.2, BA.4/5, and BA.2.75. The curve was presented by the inhibition percentage of SARS-CoV-2 pseudotyped viruses entry into host cells (mean ± SD). See also Figure S2. (b) The mean 50% neutralizing antibody titers derived from fitting the titration curves with a logistic regression model

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us